AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34477171 — intervention group
Group type: COMPARATOR
Intervention: Control group (clinic-based exercises)
Number of subjects: 17
Study 32410463 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 20
Study 32410463 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin monotherapy
Number of subjects: 20
Study 32410463 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin with bumetanide
Number of subjects: 20
Study 32410463 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin after 14 days
Number of subjects: 20
Study 32410463 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 20
Study 34752934 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated intermittent theta-burst stimulation (iTBS) administered to the left dorsolateral prefrontal cortex (DLPFC) for 14 days
Number of subjects: 60
Study 34752934 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated intermittent theta-burst stimulation (iTBS)
Number of subjects: 60
Study 34752934 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 60
Study 34337507 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical HA/CS plus an oral formulation of curcumin, quercetin, HA, and CS (group A)
Number of subjects: 49
Study 34337507 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group B)
Number of subjects: 49
Study 35366328 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help Spanish-language smoking cessation intervention
Number of subjects: 1028
Study 33483790 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported home‐based progressive resistance exercise training (RET) for 6 months, 3 sessions per week, using resistance bands
Number of subjects: 40
Study 33483790 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study 32466961 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib followed by Sorafenib (SU/SO)
Number of subjects: 120
Study 32466961 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib followed by Sunitinib (SO/SU)
Number of subjects: 120
Study 35978946 — intervention group
Group type: EXPERIMENTAL
Intervention: MCI with hearing impairment (MCI‐HI)
Number of subjects: 90
Study 35978946 — intervention group
Group type: COMPARATOR
Intervention: MCI without hearing impairment (MCI‐nHI)
Number of subjects: 90
Study 35978946 — intervention group
Group type: COMPARATOR
Intervention: No MCI (nMCI)
Number of subjects: 90
Study 35406085 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral nutritional supplement (ONS)
Number of subjects: 67
Study 35406085 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice alone (DA)
Number of subjects: 67
Study 33481203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 4 weeks in ADOL trial
Number of subjects: 508
Study 33481203 — intervention group
Group type: COMPARATOR
Intervention: Placebo in ADOL trial
Number of subjects: 508
Study 33481203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab in PED-OLE trial (2 mg/kg or 4 mg/kg weekly, up to 300 mg)
Number of subjects: 508
Study 33481203 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 200 or 300 mg every 2 weeks in QUEST trial
Number of subjects: 508
Study 33481203 — intervention group
Group type: COMPARATOR
Intervention: Placebo in QUEST trial
Number of subjects: 508
Study 32727603 — intervention group
Group type: EXPERIMENTAL
Intervention: Hestelia Mite Bait intervention for 8 weeks
Number of subjects: 60
Study 32727603 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention for 8 weeks
Number of subjects: 60
Study 32727603 — intervention group
Group type: EXPERIMENTAL
Intervention: Hestelia Mite Bait intervention
Number of subjects: 60
Study 33502545 — intervention group
Group type: EXPERIMENTAL
Intervention: Fungal-NOE
Number of subjects: 30
Study 33502545 — intervention group
Group type: EXPERIMENTAL
Intervention: PA-NOE
Number of subjects: 30
Study 33502545 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile-NOE
Number of subjects: 30
Study 33502545 — intervention group
Group type: COMPARATOR
Intervention: Fungal-NOE and PA-NOE
Number of subjects: 30
Study 33502545 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 30
Study 34224214 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine-montelukast fixed-dose combination tablet (120 mg fexofenadine and 10 mg montelukast)
Number of subjects: 78
Study 32347005 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA + DEX
Number of subjects: 100
Study 32347005 — intervention group
Group type: COMPARATOR
Intervention: TXA
Number of subjects: 100
Study 35916876 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity (HI) resistance exercise group
Number of subjects: 24
Study 35916876 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Volume (HV) resistance exercise group
Number of subjects: 24
Study 35916876 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 24
Study 33316282 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 4289
Study 33316282 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4289
Study 33316282 — intervention group
Group type: COMPARATOR
Intervention: Canagliflozin vs Placebo
Number of subjects: 4289
Study 35905073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-banded small-sided games (SSG)
Number of subjects: 32
Study 35905073 — intervention group
Group type: COMPARATOR
Intervention: Mixed maturity SSG
Number of subjects: 32
Study 35905073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-banded games
Number of subjects: 32
Study 33894577 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 66
Study 33894577 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 66
Study 35255897 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted teaching strategies based on experiential learning styles
Number of subjects: 78
Study 33627186 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative therapy based on Ayurveda and Yoga
Number of subjects: 1
Study 33627186 — intervention group
Group type: COMPARATOR
Intervention: Modern western medicine (MWM)
Number of subjects: 1
Study 33861459 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate every 24 hours for 5 days
Number of subjects: 36
Study 33861459 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 36
Study 33861657 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin 140 mg three times a day
Number of subjects: 30
Study 33861657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33844901 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 61
Study 33844901 — intervention group
Group type: COMPARATOR
Intervention: Control group (psycho-education)
Number of subjects: 61
Study 35272210 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA-assisted therapy (MDMA-AT)
Number of subjects: 89
Study 35272210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 34554691 — intervention group
Group type: COMPARATOR
Intervention: rTMS alone (group I)
Number of subjects: 83
Study 34554691 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS and amitriptyline (group II)
Number of subjects: 83
Study 34554691 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 83
Study 35441854 — intervention group
Group type: EXPERIMENTAL
Intervention: Local estradiol (twice weekly estradiol cream from delivery through 3 months postpartum)
Number of subjects: 59
Study 35441854 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream (twice weekly from delivery through 3 months postpartum)
Number of subjects: 59
Study 33993178 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative fixation
Number of subjects: 95
Study 33993178 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative management
Number of subjects: 95
Study 32013913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC) injection at the end of pars plana vitrectomy
Number of subjects: 30
Study 32013913 — intervention group
Group type: COMPARATOR
Intervention: Control group (no IVC injection)
Number of subjects: 30
Study 32013913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal conbercept (IVC) injection
Number of subjects: 30
Study 32013913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (IVC and control)
Number of subjects: 30
Study 35524794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 97
Study 35524794 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 97
Study 33462918 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency spinal cord stimulation (LF-SCS)
Number of subjects: 41
Study 33462918 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-kHz spinal cord stimulation (10-kHz SCS)
Number of subjects: 41
Study 33462918 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 41
Study 34009790 — intervention group
Group type: EXPERIMENTAL
Intervention: Head and neck cooling treatment applied at postinjury assessment visit and at 72 hours post-injury
Number of subjects: 55
Study 34009790 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (short term brain rest)
Number of subjects: 55
Study 34180719 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCs transplantation therapy (3 × 10^6 cells/kg, intravenously) on treatment days 0, 3, and 6
Number of subjects: 30
Study 34180719 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Group 1 and Group 2)
Number of subjects: 30
Study 34180719 — intervention group
Group type: EXPERIMENTAL
Intervention: MSCs transplantation therapy (Group 3)
Number of subjects: 30
Study 35849434 — intervention group
Group type: EXPERIMENTAL
Intervention: Teramune Bronchus
Number of subjects: 35
Study 35849434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 32111302 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.069 mg/kg 25-Hydroxycholecalciferol (25-OH-D3) in NRC vitamin premix
Number of subjects: 768
Study 32111302 — intervention group
Group type: COMPARATOR
Intervention: NRC vitamin premix
Number of subjects: 768
Study 32111302 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.069 mg/kg 25-Hydroxycholecalciferol (25-OH-D3) in standard nutrient density diet with NRC vitamin premix
Number of subjects: 768
Study 35971137 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 sessions of symptom-specific CBT-VR plus treatment as usual
Number of subjects: 256
Study 35971137 — intervention group
Group type: COMPARATOR
Intervention: 10 sessions of standard symptom-specific CBT for paranoid ideations (CBT) plus treatment as usual
Number of subjects: 256
Study 33580867 — intervention group
Group type: EXPERIMENTAL
Intervention: canagliflozin + standard of care (SoC)
Number of subjects: 10142
Study 33580867 — intervention group
Group type: COMPARATOR
Intervention: standard of care (SoC) alone
Number of subjects: 10142
Study 32142141 — intervention group
Group type: EXPERIMENTAL
Intervention: OsMYB80 mutants
Number of subjects: 2
Study 32142141 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA-seq analysis
Number of subjects: 2
Study 32142141 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA affinity purification sequencing (DAP-seq)
Number of subjects: 2
Study 32142141 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional annotation of the 188 genes
Number of subjects: 2
Study 35962688 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume Ringer's solution infusion
Number of subjects: 0
Study 35962688 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34842533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation therapy (KAD_SCL_01)
Number of subjects: 29
Study 34842533 — intervention group
Group type: COMPARATOR
Intervention: Commercial video games
Number of subjects: 29
Study 32186161 — intervention group
Group type: EXPERIMENTAL
Intervention: Huangban Bianxing One decoction (HBOD) combined with ranibizumab
Number of subjects: 75
Study 32186161 — intervention group
Group type: COMPARATOR
Intervention: ranibizumab
Number of subjects: 75
Study 35044841 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual collaboration
Number of subjects: 0
Study 35044841 — intervention group
Group type: EXPERIMENTAL
Intervention: Live collaboration
Number of subjects: 0
Study 35044841 — intervention group
Group type: COMPARATOR
Intervention: No collaboration
Number of subjects: 0
Study 34545454 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-adhesion material
Number of subjects: 120
Study 34545454 — intervention group
Group type: COMPARATOR
Intervention: Non-using group (Control)
Number of subjects: 120
Study 34435253 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium bristle toothbrush
Number of subjects: 20
Study 34435253 — intervention group
Group type: COMPARATOR
Intervention: Soft bristle toothbrush
Number of subjects: 20
Study 33738464 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked applications (no GRE results)
Number of subjects: 0
Study 33738464 — intervention group
Group type: COMPARATOR
Intervention: Unmasked applications (with GRE results)
Number of subjects: 0
Study 33738464 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of URM and non-URM applicants
Number of subjects: 0
Study 36432449 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-year intervention based on the Mediterranean diet including group nutritional education, individualized dietary treatment, and physical activity program
Number of subjects: 51
Study 36432449 — intervention group
Group type: COMPARATOR
Intervention: Control group received Mediterranean nutritional education in written format
Number of subjects: 51
Study 34660639 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent MTrPs injection
Number of subjects: 112
Study 34660639 — intervention group
Group type: COMPARATOR
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 112
Study 34660639 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 112
Study 34919104 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutraceutical containing 3 g d‐1 or 5 g d‐1 doses of 35% or 70% BG with 600 mg d‐1 of GCBE
Number of subjects: 60
Study 34919104 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g - 70% BG
Number of subjects: 60
Study 32007207 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg plus standard antiemetic therapy
Number of subjects: 0
Study 32007207 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard antiemetic therapy
Number of subjects: 0
Study 34974824 — intervention group
Group type: EXPERIMENTAL
Intervention: DoIT performed once weekly (DoIT-1, n=24)
Number of subjects: 97
Study 34974824 — intervention group
Group type: EXPERIMENTAL
Intervention: DoIT performed twice weekly (DoIT-2, n=23)
Number of subjects: 97
Study 34974824 — intervention group
Group type: EXPERIMENTAL
Intervention: DoIT performed thrice weekly (DoIT-3, n=21)
Number of subjects: 97
Study 34974824 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control (CON, n=29)
Number of subjects: 97
Study 33843577 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA ST45 isolates from TSAR surveys (1998-2014)
Number of subjects: 9554
Study 33843577 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA ST45 isolates from CGMH laboratory (1995-2017)
Number of subjects: 9554
Study 33843577 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS) analysis of 75 randomly selected isolates
Number of subjects: 9554
Study 35848865 — intervention group
Group type: EXPERIMENTAL
Intervention: AFM13
Number of subjects: 25
Study 32842783 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 636
Study 32842783 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 636
Study 32842783 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 636
Study 35428979 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (cord clamping after more than 60 seconds or when the cord had stopped pulsing)
Number of subjects: 122
Study 35428979 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (cord clamping within 15 seconds after birth)
Number of subjects: 122
Study 35428979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (comparison of maternal blood loss)
Number of subjects: 122
Study 33396972 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 g bovine colostrum orally twice a day for 24 weeks
Number of subjects: 27
Study 33396972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 35279470 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin users (327 patients with DM)
Number of subjects: 5922
Study 35279470 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-metformin users (294 patients with DM)
Number of subjects: 5922
Study 35279470 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients (with DM)
Number of subjects: 5922
Study 33980057 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Aid Tool (DAT) for LT4 dosage adjustment
Number of subjects: 145
Study 33980057 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DAT)
Number of subjects: 145
Study 32829666 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive BP target (office systolic BP <120 mm Hg)
Number of subjects: 897
Study 32829666 — intervention group
Group type: COMPARATOR
Intervention: Standard BP target (office systolic BP <140 mm Hg)
Number of subjects: 897
Study 35268025 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional diet (n = 41)
Number of subjects: 70
Study 35268025 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH diet (n = 29)
Number of subjects: 70
Study 35268025 — intervention group
Group type: EXPERIMENTAL
Intervention: FTO haplotype rs9939609:rs17817449
Number of subjects: 70
Study 33594986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 200.000 IU Cholecalciferol per month
Number of subjects: 60
Study 33594986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33082407 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking protocols with quasi‐static Gaussian noise model
Number of subjects: 0
Study 33082407 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized benchmarking protocols with 1/f noise model
Number of subjects: 0
Study 35410145 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified comprehensive geriatric assessment and monthly standardized case conferencing
Number of subjects: 309
Study 35410145 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 309
Study 33769849 — intervention group
Group type: EXPERIMENTAL
Intervention: Training with anchors with immediate feedback (Group F)
Number of subjects: 48
Study 33769849 — intervention group
Group type: COMPARATOR
Intervention: Training without immediate feedback (Group NF)
Number of subjects: 48
Study 33769849 — intervention group
Group type: COMPARATOR
Intervention: Sham training (Group C)
Number of subjects: 48
Study 33769849 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 48
Study 35524357 — intervention group
Group type: EXPERIMENTAL
Intervention: C1-inhibitor (C1-INH) subcutaneous (SC) 60 IU/kg twice weekly for 52 weeks
Number of subjects: 63
Study 33183577 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (LFD)
Number of subjects: 29
Study 33183577 — intervention group
Group type: COMPARATOR
Intervention: Low lactose diet (LLD)
Number of subjects: 29
Study 35573632 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (three half-hour sessions with a 3-day interval, including posthypnotic suggestion recordings)
Number of subjects: 80
Study 35573632 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study 34216524 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit blood pressure variability (BPV) measured as variability independent of the mean (VIM)
Number of subjects: 4050
Study 34216524 — intervention group
Group type: EXPERIMENTAL
Intervention: Visit-to-visit blood pressure variability (BPV) measured as maximum minus minimum difference (MMD)
Number of subjects: 4050
Study 34216524 — intervention group
Group type: COMPARATOR
Intervention: Highest quintile of BPV
Number of subjects: 4050
Study 34216524 — intervention group
Group type: EXPERIMENTAL
Intervention: 3rd tertile of SBP VIM in high-risk group
Number of subjects: 4050
Study 34216524 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive-therapy group
Number of subjects: 4050
Study 34216524 — intervention group
Group type: EXPERIMENTAL
Intervention: 3rd tertile of SBP MMD in high-risk group
Number of subjects: 4050
Study 35146580 — intervention group
Group type: EXPERIMENTAL
Intervention: FIR (n = 7)
Number of subjects: 14
Study 35146580 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 7)
Number of subjects: 14
Study 34527310 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 45
Study 34527310 — intervention group
Group type: COMPARATOR
Intervention: Positive Expiratory Pressure (PEP)
Number of subjects: 45
Study 36818484 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine (0.5 µg/kg)
Number of subjects: 80
Study 36818484 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 80
Study 32640368 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping skills training (CST)
Number of subjects: 1953
Study 36437767 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + PRO (Resistance Training + Whey Protein Supplementation)
Number of subjects: 81
Study 36437767 — intervention group
Group type: COMPARATOR
Intervention: RT (Resistance Training only)
Number of subjects: 81
Study 36437767 — intervention group
Group type: COMPARATOR
Intervention: PRO (Whey Protein Supplementation only)
Number of subjects: 81
Study 36245315 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EAG) three times a week for 4 weeks
Number of subjects: 84
Study 36245315 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (ATG) four times per day for 4 weeks
Number of subjects: 84
Study 32928030 — intervention group
Group type: EXPERIMENTAL
Intervention: IC‐ECG location (observation group)
Number of subjects: 158